Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects

Eur Neuropsychopharmacol. 2013 Aug;23(8):852-64. doi: 10.1016/j.euroneuro.2012.10.006. Epub 2012 Nov 21.

Abstract

Previous postmortem and neuroimaging studies have repeatedly suggested alterations in serotonin 5-HT(2A) receptor (5-HT(2A)R) binding associated with the pathophysiology of schizophrenia. These studies were performed with ligands, such as ketanserin, altanserin and LSD, that may bind with high-affinity to different structural or functional conformations of the 5-HT(2A)R. Interpretation of results may also be confounded by chronic antipsychotic treatment and suicidal behavior in the schizophrenia group. We quantified 5-HT(2A)R density by radioligand binding assays in postmortem prefrontal cortex of antipsychotic-free (n=29) and antipsychotic-treated (n=16) schizophrenics, suicide victims with other psychiatric diagnoses (n=13), and individually matched controls. [³H]Ketanserin binding, and its displacement by altanserin or the LSD-like agonist DOI, was assayed. Results indicate that the number of [³H]ketanserin binding sites to the 5-HT(2A)R was increased in antipsychotic-free (128 ± 11%), but not in antipsychotic-treated (92 ± 12%), schizophrenic subjects. In suicide victims, [³H]ketanserin binding did not differ as compared to controls. Aging correlated negatively with [³H]ketanserin binding in schizophrenia, suicide victims and controls. The fraction of high-affinity sites of DOI displacing [³H]ketanserin binding to the 5-HT(2A)R was increased in antipsychotic-free schizophrenic subjects. Functional uncoupling of heterotrimeric G proteins led to increased fraction of high-affinity sites of altanserin displacing [³H]ketanserin binding to the 5-HT(2A)R in schizophrenic subjects, but not in controls. Together, these results suggest that the active conformation of the 5-HT(2A)R is up-regulated in prefrontal cortex of antipsychotic-free schizophrenic subjects, and may provide a pharmacological explanation for discordant findings previously obtained.

Keywords: Postmortem human brain; Radioligand binding; Schizophrenia; Serotonin; Serotonin 5-HT2A receptor; Suicide.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphetamines / metabolism
  • Animals
  • Antipsychotic Agents / therapeutic use
  • Diagnostic and Statistical Manual of Mental Disorders
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism
  • Humans
  • Ketanserin / analogs & derivatives
  • Ketanserin / metabolism
  • Mice
  • Mice, Knockout
  • Nerve Tissue Proteins / agonists
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / metabolism*
  • Neurons / drug effects
  • Neurons / metabolism*
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / metabolism*
  • Radioligand Assay
  • Receptor, Serotonin, 5-HT2A / chemistry
  • Receptor, Serotonin, 5-HT2A / genetics
  • Receptor, Serotonin, 5-HT2A / metabolism*
  • Schizophrenia / drug therapy
  • Schizophrenia / metabolism*
  • Serotonin Antagonists / metabolism
  • Serotonin Receptor Agonists / metabolism
  • Suicide
  • Up-Regulation* / drug effects

Substances

  • Amphetamines
  • Antipsychotic Agents
  • Nerve Tissue Proteins
  • Receptor, Serotonin, 5-HT2A
  • Serotonin Antagonists
  • Serotonin Receptor Agonists
  • altanserin
  • Ketanserin
  • 4-iodo-2,5-dimethoxyphenylisopropylamine